TTK Healthcare
NSE: TTKHLTCARE · ISIN INE910C01018 · Healthcare
₹936.60+4.85 (+0.52%)
Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.
Price chart
₹936.60 +4.85 (+0.52%) today
The day
- Previous close
- ₹931.75
- Open
- ₹924.00
- Day high
- ₹938.95
- Day low
- ₹924.00
Listed on NSE since 2 December 2015.
Key numbers
- Market value
- ₹1,323.45 Cr
- P/E (trailing)
- 4.79
- EPS (trailing)
- ₹195.71
- Price to book
- 0.98
- Dividend yield
- 1.07%
- Return on equity
- 22.7%
- Debt to equity
- 0.02
- Profit margin
- 30.1%
- Beta
- 0.40
- Volume today
- 2,695
- Average volume
- 34,277
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹720.19 Cr | ₹639.71 Cr |
| FY24 | ₹747.64 Cr | ₹62.84 Cr |
| FY25 | ₹797.63 Cr | ₹81.66 Cr |
| FY26 | ₹854.38 Cr | ₹65.68 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹233 Cr | ₹223 Cr | +993.7% |
| Q1 FY27Apr–Jun 2026 | ₹258 Cr | ₹21 Cr | +63.7% |
| Q4 FY26Jan–Mar 2026Audited | ₹218 Cr | ₹22 Cr | +34.8% |
| Q3 FY26Oct–Dec 2025 | ₹209 Cr | ₹11 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹204 Cr | ₹20 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹226 Cr | ₹13 Cr | – |
Source: TTK Healthcare’s results filed with NSE, standalone (the company alone). Net profit is the share of TTK Healthcare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹66 Cr | ₹74 Cr |
| Investments | ₹12 Cr | ₹9 Cr |
| Inventories | ₹113 Cr | ₹109 Cr |
| Owed by customers | ₹117 Cr | ₹111 Cr |
| Cash and equivalents | ₹90 Cr | ₹22 Cr |
| Total assets | ₹1,651 Cr | ₹1,329 Cr |
| Borrowings | ₹26 Cr | ₹24 Cr |
| Total liabilities | ₹305 Cr | ₹214 Cr |
| Shareholders’ equity | ₹1,347 Cr | ₹1,115 Cr |
Source: TTK Healthcare’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About TTK Healthcare
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Foods, Protective Devices and Other segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
- Industry
- Drug Manufacturers - General
- Based in
- Chennai
- Employees
- 1,384
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name TTK Healthcare in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 10 Per Share
Dividend · ex-date 17 July 2026
- Annual General Meeting/Dividend - Rs 10 Per Share
Dividend · ex-date 18 July 2025
- Annual General Meeting/Dividend - Rs10 Per Sh/
Dividend · ex-date 16 July 2024
- Annual General Meeting/Dividend - Rs 10 Per Share
Dividend · ex-date 18 July 2023
- Annual General Meeting/Dividend - Rs 10 Per Share
Dividend · ex-date 26 July 2022
- Annual General Meeting/Dividend - Rs 6 Per Share
Dividend · ex-date 12 August 2021
- Annual General Meeting/Dividend - Rs 3 Per Share
Dividend · ex-date 3 September 2020
- Annual General Meeting/Dividend - Rs 5 Per Share
Dividend · ex-date 1 August 2019
Source: NSE. Latest first, 8 of 11.
Information only, not investment advice. Prices are delayed.